Regenerative Medicine Innovator QC Kinetix Revolutionizes the Medical Field

QC Kinetix is a leading regenerative medicine company that has quickly gained prominence since its establishment in 2017. Offering innovative, non-surgical solutions for joint pain and discomfort, the company now serves patients in over 100 cities nationwide. Its therapies focus on stimulating the body’s regenerative capabilities to improve musculoskeletal health without the need for surgery.

In May 2024, QC Kinetix achieved recognition from Entrepreneur magazine as one of the top 10 New and Emerging Franchises of 2024, climbing to the 9th spot. This accolade reflects the company’s significant growth, with a 2,111% increase in units over the past three years, demonstrating strong financial health and brand influence.

“We’re honored to rank among some of the fastest-growing franchise brands,” remarked the CEO of QC Kinetix. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”

QC Kinetix Stands Supported by Industry Leaders

QC Kinetix is committed to offering a superior alternative for pain management. Motivated by a profound commitment to improving lives, QC offers effective treatments for chronic pain without relying on medications, surgeries, or steroids. Their approach uses proprietary biologics treatment protocols, demonstrating their dedication to patient care through successful treatments of thousands.

Recently, the company welcomed Dr. Mitchell Sheinkop as the national medical director. Dr. Sheinkop, a globally recognized orthopedic surgeon, brings over 37 years of expertise in joint replacement. His involvement underscores his faith in regenerative medicine’s potential and dedication to patient care.

In his role, Dr. Sheinkop leads the medical management team, optimizing treatment protocols and spearheading research initiatives. He plans to integrate physical therapy and weight management into the treatment plans to boost patient outcomes and satisfaction, enhancing the brand’s impact.

Under Dr. Sheinkop’s leadership, QC Kinetix embarked on an exciting new chapter, leveraging his extensive clinical experience and commitment to professional development to propel the company to new heights of innovation and achievement.

Pro Football Hall of Famer Emmitt Smith, who represents QC Kinetix as the national spokesperson, shared, “I’ve got to keep taking care of these joints,” Smith said, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.” 

Introducing QC Kinetix

The origins of QC Kinetix trace back to a room where a medical doctor, a physician assistant, a nurse practitioner, and a business professional converged, each bringing a vision. They decided to pay tribute to their origins in Charlotte, North Carolina, lovingly referred to as “the Queen City” (QC), which inspired the naming of the company.

“Kinetix” reflects the kinetic energy concept, emphasizing motion. QC Kinetix’s mission is to restore movement using the body’s cells for growth regeneration.

The founders saw a substantial opportunity to revolutionize the treatment of musculoskeletal pain with a pioneering, healthier approach. They established a concierge medical model focusing on regenerative medicine to enhance patients’ quality of life. This innovative spirit distinguishes QC Kinetix, continually driving advancements in regenerative medicine.

Many patients come to QC Kinetix struggling with pain that hinders their enjoyment of activities like golf, climbing stairs, or playing with grandchildren. The clinic offers advanced treatment options that steer clear of harmful medications and risky surgeries.

“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” explained a company spokesperson. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”

QC Kinetix Embraces a Patient-Centric Treatment Model

As a leader in regenerative medicine, QC Kinetix helps individuals maintain active lifestyles by treating musculoskeletal and joint pain with comprehensive, regenerative medicine treatments.

They leverage the body’s innate healing abilities through advanced natural biological treatments, offering alternatives to invasive surgeries and addictive medications.

The clinics focus on enhancing the body’s natural repair mechanisms from within, significantly improving functionality and overall life quality.

Patients often seek treatment for knee, shoulder, or hip pain. QC Kinetix’s treatments leverage the body’s natural regenerative capabilities, achieving significant milestones since the company’s founding.

In 2023, QC Kinetix surpassed $100 million in system-wide sales, and by April 2024, they had served their 40,000th patient since their national expansion began in 2021.

“It is our goal to change medicine,” the CEO of QC Kenetix shared. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”

QC Kinetix is Poised for Monumental Global Expansion

With a robust presence in the U.S., QC Kinetix now eyes global markets, planning entries into the United Kingdom, Australia, and New Zealand. This expansion will further cement its role as a worldwide leader in regenerative medicine, aiming for 250 open locations across the U.S. by the end of 2024.

Reflecting on the company’s rapid growth, the CEO noted, “The only surprise is that our expansion hasn’t been quicker, given the high demand for alternatives to conventional pain treatments. This growth underscores the strong market demand for non-surgical pain relief options and the keen interest from franchise investors in the healthcare sector.”

“I love this brand and our future,” the CEO of QC Kinetix said. “It’s about impacting people’s lives and being a game-changer in the medical field.”